Login / Signup

Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs.

Maria KalweitAndrea M. BurdenJoschka BoedeckerThomas HügleTheresa Burkard
Published in: PLoS Comput. Biol. (2023)
Keyphrases